View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. SHL
23 September 2019

SHL Joins PODD Conference on 7-8 October

SHL will proudly make its first appearance at the 2019 Partnership Opportunities in Drug Delivery (PODD) Conference on 7-8 October, showcasing at Booth 24, the Renaissance Boston Waterfront Hotel in Boston.

The company’s debut exhibit will feature a vast array of products that provide solutions for the growing demands in self-injection treatments. Displays include Needle Isolation Technology (NIT®) – a pre-attached needle mechanism for cartridge-based auto-injectors that eliminates the need for users to manually attach the needle or directly contact with the needle upon injection preparation; the refined Molly® variation – an auto-injector family that offers devices for drug fill volumes up to 2.25mL and is designed to be mass-produced effectively and efficiently.

Owning 30 years of experience and industry knowledge, SHL continues to thrive in the self-injection treatment space, offering pharma companies a broad scope of services that include the design, development and manufacturing of advanced drug delivery systems.

For more information on the event, or for the products and services SHL provide, please fill out the enquiry form attached to this page.

SHL has extensive experience in the parenteral arena. In this article, SHL details its latest offerings in the world of biologics, as well as its...
Despite being founded in an age when medical devices were more about getting the job done than providing optimum patient experience, SHL Group has from...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU